Patient reported trial outcomes

What about the cost to use the measures?

BMJ 2009; 338 doi: 10.1136/bmj.b387 (Published 2 February 2009)
Cite this as: BMJ 2009;338:b387

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Jens M Lauritsen, consultant1
  1. 1Orthopaedic Department, Accident Analysis Group, Odense University Hospital, DK5000 Odense C, Denmark
  1. jens.lauritsen{at}ouh.regionsyddanmark.dk

    Garratt highlights the standard use of patient reported outcome measures in trials.1 He advocates SF36 but does not mention that you must pay to …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL